LifeMD, Inc. (NASDAQ: LFMDP) Stock Competitors & Peer Comparison
See LFMDP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LFMDP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LFMDP | $23.23 | -0.43% | 158.9M | -718.03 | -$0.03 | N/A |
| RPRX | $61.45 | -0.45% | 26.9B | 11.54 | $5.25 | +1.52% |
| CORT | $121.29 | +1.90% | 13.1B | 345.86 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $68.53 | -9.03% | 6.3B | 507.50 | $0.14 | N/A |
| KNSA | $79.37 | -1.77% | 6B | 87.19 | $0.90 | N/A |
| TRLV | $10.91 | +8.13% | 1.7B | -24.40 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $21.74 | +3.82% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
LFMDP vs RPRX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, RPRX has a market cap of 26.9B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while RPRX trades at $61.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas RPRX's P/E ratio is 11.54. In terms of profitability, LFMDP's ROE is -1.79%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, LFMDP is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
LFMDP vs CORT Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, CORT has a market cap of 13.1B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while CORT trades at $121.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas CORT's P/E ratio is 345.86. In terms of profitability, LFMDP's ROE is -1.79%, compared to CORT's ROE of +0.08%. Regarding short-term risk, LFMDP is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
LFMDP vs WBA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas WBA's P/E ratio is -1.64. In terms of profitability, LFMDP's ROE is -1.79%, compared to WBA's ROE of -0.42%. Regarding short-term risk, LFMDP is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
LFMDP vs LQDA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, LQDA has a market cap of 6.3B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while LQDA trades at $68.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas LQDA's P/E ratio is 507.50. In terms of profitability, LFMDP's ROE is -1.79%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, LFMDP is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
LFMDP vs KNSA Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while KNSA trades at $79.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas KNSA's P/E ratio is 87.19. In terms of profitability, LFMDP's ROE is -1.79%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, LFMDP is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
LFMDP vs TRLV Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, TRLV has a market cap of 1.7B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while TRLV trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas TRLV's P/E ratio is -24.40. In terms of profitability, LFMDP's ROE is -1.79%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, LFMDP is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
LFMDP vs HROWL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas HROWL's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, LFMDP is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
LFMDP vs HROWM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas HROWM's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, LFMDP is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
LFMDP vs LTGO Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, LTGO has a market cap of 1.3B. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while LTGO trades at $21.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas LTGO's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to LTGO's ROE of N/A. Regarding short-term risk, LFMDP is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
LFMDP vs CUVL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, CUVL has a market cap of 393.3M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while CUVL trades at $7.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas CUVL's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to CUVL's ROE of N/A. Regarding short-term risk, LFMDP is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
LFMDP vs LFMD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, LFMD has a market cap of 158.6M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while LFMD trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas LFMD's P/E ratio is -6.56. In terms of profitability, LFMDP's ROE is -1.79%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, LFMDP is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check LFMD's competition here
Stablecoin Development Corp. (AMEX: SDEV)
LFMDP vs SDEV Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, SDEV has a market cap of 55.5M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while SDEV trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas SDEV's P/E ratio is -0.19. In terms of profitability, LFMDP's ROE is -1.79%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, LFMDP is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SDEV's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
LFMDP vs CIRC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, CIRC has a market cap of 54M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while CIRC trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas CIRC's P/E ratio is -1.36. In terms of profitability, LFMDP's ROE is -1.79%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, LFMDP is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
LFMDP vs RAD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas RAD's P/E ratio is -0.05. In terms of profitability, LFMDP's ROE is -1.79%, compared to RAD's ROE of +2.76%. Regarding short-term risk, LFMDP is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
LFMDP vs GLTO Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas GLTO's P/E ratio is -1.78. In terms of profitability, LFMDP's ROE is -1.79%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, LFMDP is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
LFMDP vs NSRX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, NSRX has a market cap of 33.2M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while NSRX trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas NSRX's P/E ratio is -5.35. In terms of profitability, LFMDP's ROE is -1.79%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, LFMDP is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
LFMDP vs SCYX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, SCYX has a market cap of 32.8M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while SCYX trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas SCYX's P/E ratio is -1.53. In terms of profitability, LFMDP's ROE is -1.79%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, LFMDP is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SCYX's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
LFMDP vs AIXC Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, AIXC has a market cap of 23.8M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while AIXC trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas AIXC's P/E ratio is -0.13. In terms of profitability, LFMDP's ROE is -1.79%, compared to AIXC's ROE of -0.97%. Regarding short-term risk, LFMDP is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check AIXC's competition here
Cerenome, Inc. (NASDAQ: CNSY)
LFMDP vs CNSY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, CNSY has a market cap of 20.6M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while CNSY trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas CNSY's P/E ratio is -0.42. In terms of profitability, LFMDP's ROE is -1.79%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, LFMDP is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
LFMDP vs BFRI Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, BFRI has a market cap of 18.9M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while BFRI trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas BFRI's P/E ratio is -2.69. In terms of profitability, LFMDP's ROE is -1.79%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, LFMDP is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
LFMDP vs CJJD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas CJJD's P/E ratio is -0.46. In terms of profitability, LFMDP's ROE is -1.79%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, LFMDP is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
LFMDP vs SSY Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas SSY's P/E ratio is -2.86. In terms of profitability, LFMDP's ROE is -1.79%, compared to SSY's ROE of -0.09%. Regarding short-term risk, LFMDP is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
LFMDP vs POM Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, POM has a market cap of 7.1M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while POM trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas POM's P/E ratio is -0.21. In terms of profitability, LFMDP's ROE is -1.79%, compared to POM's ROE of +0.16%. Regarding short-term risk, LFMDP is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check POM's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
LFMDP vs BGMS Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, BGMS has a market cap of 4.8M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while BGMS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas BGMS's P/E ratio is -0.25. In terms of profitability, LFMDP's ROE is -1.79%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, LFMDP is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BGMS's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
LFMDP vs PAVS Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, PAVS has a market cap of 4.5M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while PAVS trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas PAVS's P/E ratio is -0.06. In terms of profitability, LFMDP's ROE is -1.79%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, LFMDP is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
LFMDP vs HKPD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, HKPD has a market cap of 4.4M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while HKPD trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas HKPD's P/E ratio is -6.67. In terms of profitability, LFMDP's ROE is -1.79%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, LFMDP is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check HKPD's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
LFMDP vs MDVL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas MDVL's P/E ratio is -0.05. In terms of profitability, LFMDP's ROE is -1.79%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, LFMDP is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
LFMDP vs ATNFW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas ATNFW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, LFMDP is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
LFMDP vs BGMSP Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, LFMDP's ROE is -1.79%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, LFMDP is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
LFMDP vs AZNH Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas AZNH's P/E ratio is 38.35. In terms of profitability, LFMDP's ROE is -1.79%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, LFMDP is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
LFMDP vs LFLYW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, LFMDP's ROE is -1.79%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, LFMDP is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
LFMDP vs SBFMW Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, SBFMW has a market cap of 249.8K. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while SBFMW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas SBFMW's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to SBFMW's ROE of -0.24%. Regarding short-term risk, LFMDP is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check SBFMW's competition here
POZEN Inc. (NASDAQ: POZN)
LFMDP vs POZN Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, POZN has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas POZN's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to POZN's ROE of +0.61%. Regarding short-term risk, LFMDP is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check POZN's competition here
Shire plc (NASDAQ: SHPG)
LFMDP vs SHPG Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas SHPG's P/E ratio is 11.35. In terms of profitability, LFMDP's ROE is -1.79%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, LFMDP is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check SHPG's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
LFMDP vs CPD Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, CPD has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas CPD's P/E ratio is N/A. In terms of profitability, LFMDP's ROE is -1.79%, compared to CPD's ROE of N/A. Regarding short-term risk, LFMDP is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check CPD's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
LFMDP vs OREX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, OREX has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas OREX's P/E ratio is -0.14. In terms of profitability, LFMDP's ROE is -1.79%, compared to OREX's ROE of -0.54%. Regarding short-term risk, LFMDP is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
LFMDP vs IPXL Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas IPXL's P/E ratio is -10.11. In terms of profitability, LFMDP's ROE is -1.79%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, LFMDP is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for LFMDP.Check IPXL's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
LFMDP vs ESRX Comparison August 2026
LifeMD, Inc. (NASDAQ: LFMDP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMDP stands at 158.9M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, LFMDP is priced at $23.23 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMDP currently has a P/E ratio of -718.03, whereas ESRX's P/E ratio is 10.69. In terms of profitability, LFMDP's ROE is -1.79%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, LFMDP is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for LFMDP.Check ESRX's competition here